What sounds like a dream of the future has already been the subject of research for a few years: simply printing out tissue and organs.
Now scientists have further refined the technology and are able to produce various tissue types.
The recent organ transplant scandals have only made the problem worse. According to the German Organ Transplantation Foundation (DSO), the number of organ donors in the first half of 2013 has declined more than 18 percent in comparison to the same period the previous year. At the same time, one can assume that the demand in the next years will continuously rise, because we continue to age and field of transplantation medicine is continuously advancing. Many critical illnesses can already be successfully treated today by replacing cells, tissue, or organs. Government, industry, and the research establishment have therefore been working hard for some time to improve methods and procedures for artificially producing tissue. This is how the gap in supply is supposed to be closed.
Bio-ink made from living cells
One technology might assume a decisive role in this effort, one that we are all familiar with from the office, and that most of us would certainly not immediately connect with the production of artificial tissue: the inkjet printer. Scientists of the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart have succeeded in developing suitable bio-inks for this printing technology. The transparent liquids consist of components from the natural tissue matrix and living cells. The substance is based on a well known biological material: gelatin. Gelatin is derived from collagen, the main constituent of native tissue. The researchers have chemically modified the gelling behavior of the gelatin to adapt the biological molecules for printing. Instead of gelling like unmodified gelatin, the bio-inks remain fluid during printing. Only after they are irradiated with UV light, they crosslink and cure to form hydrogels.
These are polymers containing a huge amount of water (just like native tissue), but which are stable in aqueous environments and when being warmed up to physiological 37°C. The researchers can control the chemical modification of the biological molecules so that the resulting gels have differing strengths and swelling characteristics. The properties of natural tissue can therefore be imitated – from solid cartilage to soft adipose tissue.
In Stuttgart synthetic raw materials are printed as well that can serve as substitutes for the extracellular matrix. For example a system that cures to a hydrogel devoid of by-products, and can be immediately populated with genuine cells. “We are concentrating at the moment on the ‘natural’ variant. That way we remain very close to the original material. Even if the potential for synthetic hydrogels is big, we still need to learn a fair amount about the interactions between the artificial substances and cells or natural tissue. Our biomolecule-based variants provide the cells with a natural environment instead, and therefore can promote the self-organizing behavior of the printed cells to form a functional tissue model,” explains Dr. Kirsten Borchers in describing the approach at IGB.
The printers at the labs in Stuttgart have a lot in common with conventional office printers: the ink reservoirs and jets are all the same. The differences are discovered only under close inspection. For example, the heater on the ink container with which the right temperature of the bio-inks is set. The number of jets and tanks is smaller than in the office counterpart as well. “We would like to increase the number of these in cooperation with industry and other Fraunhofer Institutes in order to simultaneously print using various inks with different cells and matrices. This way we can come closer to replicating complex structures and different types of tissue,” says Borchers.
Go deeper with Bing News on:
Printing tissues and organs
- The researchers, with Google and other partners, spent a decade deciphering 1 cubic millimeter of tissue.
About 10 years ago, a small piece of human brain arrived in the lab of Dr. Jeff Lichtman at Harvard. It came directly from an operating room of a nearby hospital, where it was excised from an epilepsy ...
- Patient Who Received First Pig Kidney Transplant Dies Nearly 2 Months Post-Operation
Richard Slayman, 62, died nearly two months after receiving a genetically modified pig kidney. The Massachusetts man has been described as a beacon of hope.
- 2 Jaipur Doctors Arrested For Issuing Fake Organ Transplant Certificates
Two doctors of a private hospital in Jaipur have been arrested in connection with fake NOC for organ transplant case.
- Mass. man who received first kidney transplant from genetically engineered pig has died, family says
Our family is deeply saddened about the sudden passing of our beloved Rick but take great comfort knowing he inspired so many,” his family said in a statement Saturday.
- A Guide to 3D Printing for Healthcare, Today and Tomorrow
The technology is used by many health systems to create custom implants and models, but how will it be used in medicine as it advances?
Go deeper with Google Headlines on:
Printing tissues and organs
[google_news title=”” keyword=”Printing tissues and organs” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Bioprinting
- More people need transplants than there are organ donors. Pigs might be a solution
The need for transplant organs is immense and growing. Some scientists think animal organs might be a good way to increase the supply. Advances in cloning and gene editing have led to breakthroughs.
- New technique bioprints live cells inside the body using ultrasonic waves
Revolutionary acousto-printing method can be used to circumvent invasive surgery, and has a wide array of potential applications.
- 3D Bioprinting Market Expected to Hit USD 6.9 Billion by 2032 | Market.Us
According to a recent report by Market.us, the Global 3D Bioprinting Market size is expected to be worth around USD 6.9 Billion by 2032 from USD 1.9 Billion in 2023, growing at a CAGR of 16.1% during ...
- Advancing gastric cancer treatment through personalized 3D bioprinting
By using 3D bioprinting to accurately replicate the biological environment surrounding gastric cancer cells, the researchers have achieved a significant feat—predicting a patient's response to ...
- 3D printing and bioprinting in healthcare
3D bioprinting is a much newer technology and uses bioinks mixed with living cells to print structures to be used in the human body. A chapter on this technology is also included in this report.
Go deeper with Google Headlines on:
Bioprinting
[google_news title=”” keyword=”bioprinting” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]